Revisiting the PLATO trial
A recent BMJ investigation has rekindled the robust debate surrounding the PLATO trial of ticagrelor vs clopidogrel in patients with acute coronary syndromes
Related Articles
FDA Breakthrough Therapy Designation Granted For Promising Rectal Cancer Drug
This will speed up the development and review of this drug.
When to Stay or Leave Your Physician Job – FREE Webinar
At the free, LIVE class, you’ll get everything you need to make your decision & upgrade your job in 2025, regardless if you stay or…
Dynamic characterization of circulating tumor DNA in HER2-altered advanced non-small cell lung cancer treated with pyrotinib and apatinib: Exploratory biomarker analysis from PATHER2 study
Human epidermal receptor tyrosine kinase 2 (HER2/ERBB2) mutation is recognized as a critical driver of non-small cell lung cancer (NSCLC), occurring in approximately 2 %–3% of…
The year in cancer: Advances made in 2024, predictions for 2025
Four oncologists from the Sarah Cannon Research Institute in Tennessee shared with Fox News Digital what they see as the most notable accomplishments from 2024…
Government Funding for the Development of Enzalutamide
This cross-sectional study assesses the various patents and US government grants that were critical to the publicly funded development of the cancer drug enzalutamide.
Coldplay – ALL MY LOVE (Official Video) (Directors’ Cut)
All My Love is taken from Coldplay’s tenth studio album Moon Music, available here: https://coldplay.lnk.to/MoonMusic 🌙FOLLOW AND LISTEN TO COLDPLAYhttps://…
What Clinicians Want to Know: Biomarker Assessment and Related Treatment Decision-Making for Patients with Colorectal Cancer — Friday, January 24, 2025, San Francisco | Research To Practice
Friday, January 24, 2025, San Francisco, California, 6:00 PM – 8:00 PM Pacific Time (9:00 PM – 11:00 PM Eastern Time) Location San Francisco Marriott…
BOVen Regimen NCCN-Approved Option for TP53-Mutated MCL | ASH Clinical News | American Society of Hematology
Leah Lawrence is a freelance health writer and editor based in Delaware. The three-drug regimen of zanubrutinib, obinutuzumab, and venetoclax—dubbed the BOVen regimen—is an effective…
Government Funding for the Development of Enzalutamide
This cross-sectional study assesses the various patents and US government grants that were critical to the publicly funded development of the cancer drug enzalutamide.
RECOVER Clinical Trials | SLEEP
RECOVER-SLEEP is focused on sleep disturbances related to Long COVID, such as problems falling and staying asleep, feeling very sleepy or tired during the day,…
